This Article Full Text Full Text (PDF) Other Versions of this Article: JCM.01956-06v1 45/3/747    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marshall, R. Articles by Yu, H. Search for Related Content PubMed PubMed Citation Articles by Marshall, R. Articles by Yu, H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2007, p. 747-751, Vol. 45, No. 3
0095-1137/07/$08.00+0     doi:10.1128/JCM.01956-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Characteristics of the m2000 Automated Sample Preparation and Multiplex Real-Time PCR System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Abbott Molecular Inc., Des Plaines, Illinois,¹ McMaster University/St. Joseph's Healthcare, Hamilton, Ontario, Canada,² University of Alabama, Birmingham, Alabama,³ University of Minnesota Medical School and Hennepin County Medical Center, Minneapolis, Minnesota⁴

Received 20 September 2006/ Returned for modification 30 October 2006/ Accepted 20 December 2006

We evaluated a new real-time PCR-based prototype assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae developed by Abbott Molecular Inc. This assay is designed to be performed on an Abbott m2000 real-time instrument system, which consists of an m2000sp instrument for sample preparation and an m2000rt instrument for real-time PCR amplification and detection. The limit of detection of this prototype assay was determined to be 20 copies of target DNA for both C. trachomatis and N. gonorrhoeae, using serially diluted linearized plasmids. No cross-reactivity could be detected when 55 nongonococcal Neisseria isolates and 3 non-C. trachomatis Chlamydia isolates were tested at 1 million genome equivalents per reaction. Concordance with the Roche Amplicor, BDProbeTec ET, and Gen-Probe APTIMA Combo 2 tests was assessed using unlinked/deidentified surplus clinical specimens previously analyzed with these tests. For C. trachomatis, concordance for positive results ranged from 93.7% to 100%, while concordance for negative results ranged from 98.2% to 100%. For N. gonorrhoeae, concordance for positive and negative results ranged from 91.4% to 100% and 99.3% to 100%, respectively. A workflow analysis of the prototype assay was conducted to obtain information on throughput under laboratory conditions. At 48 samples/run, the time to first result for both C. trachomatis and N. gonorrhoeae was 4.5 h. A total of 135 patient specimens could be analyzed in 8.9 h, with 75 min of hands-on time. This study demonstrated the technical and clinical feasibility of the new Abbott real-time PCR C. trachomatis/N. gonorrhoeae assay.

Published ahead of print on 3 January 2007.

This article has been cited by other articles:

• Palmer, H M, Young, H, Graham, C, Dave, J (2008). Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex. Transm. Infect. 84: 280-284 [Abstract] [Full Text]  
• Levett, P. N., Brandt, K., Olenius, K., Brown, C., Montgomery, K., Horsman, G. B. (2008). Evaluation of Three Automated Nucleic Acid Amplification Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in First-Void Urine Specimens. J. Clin. Microbiol. 46: 2109-2111 [Abstract] [Full Text]